Back to VRDN

Elmind Capital, LP → VRDN

Elmind Capital, LP VRDN Position History

Viridian Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$25.2M
Q3 2026
Peak value
$26.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$26.7M
Q1 2026$10.5M
Q2 2026$18.1M
Q3 2026$25.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$25.2M1.22M——
Q2 2026$18.1M984.9K——
Q1 2026$10.5M534.9K——
Q4 2025$26.7M858.6K——

Other funds holding VRDN

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M